ليلي

Latest news and articles about ليلي from NEX English

Lilly Opens Access to Diabetes Treatment: CVS to Cover Costs

Lilly has announced that millions of Americans will have access to its new diabetes medications, with CVS pharmacy chain covering the costs of GLP-1 drugs like Foundayo and Zepbound. This development could significantly change the lives of many diabetes patients.

Lilly Acquires Narcolepsy Drug Developer for $7.8 Billion

Lilly, the American pharmaceutical giant, has announced its acquisition of a company specializing in the development of a drug for narcolepsy, in a deal valued at up to <strong>$7.8 billion</strong>. This move aims to expand the company's market presence and enhance its drug portfolio.